Navigation Links
Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
Date:10/29/2009

NEW YORK, Oct. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Molecular Diagnostics: A Dynamic and Rapidly Broadening Market

http://www.reportlinker.com/p0156566/Molecular-Diagnostics-A-Dynamic-and-Rapidly-Broadening-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Molecular diagnostic applications in the areas of oncology, personalized medicine, inherited disorders, prediction of genetic disease risk, and many others are rapidly increasing in number as this burgeoning field expands beyond infectious disease testing. This report focuses on these newer applications of molecular diagnostics, analyzing:

  • Established and up-and-coming technologies
  • The activities of more than 35 companies
  • More than 300 current and emerging molecular diagnostic tests for disease applications and genetic testing
  • Business considerations associated with product development, commercialization, and marketing
  • Regulatory issues
  • Challenges facing companies developing molecular diagnostics and/or companion diagnostics and targeted therapies
  • Major trends in the molecular diagnostics market, such as the increasing number of tests that are commercially available

Chapter 1

BACKGROUND AND SCOPE

1.1. Background

1.2. Focus of This Report

Chapter 2

CURRENT AND EMERGING TECHNOLOGIES

2.1. Nonamplified Probe-Based Assays

2.2. Cytogenetics and Fluorescent In Situ Hybridization (FISH)

2.3. Polymerase Chain Reaction (PCR) and Other Amplification Technologies

2.4. Microarrays and Other Multiplex Technologies

2.5. DNA Methylation Assays

Epigenomics

OncoMethylome Sciences

Orion Genomics

Rubicon Genomics

2.6. Other Current and Emerging Technologies

Chapter 3

CURRENT AND EMERGING APPLICATIONS OF MOLECULAR DIAGNOSTICS: MOVING BEYOND INFECTIOUS DISEASE TESTING

3.1. Oncology: Diagnostic, Prognostic, and Personalized Medicine Tests

Testing for HER2/neu Overexpression in Breast Cancer

Testing for Epidermal Growth Factor Receptor

Analysis of the Expression of Multiple Genes for Breast Cancer

Prognosis and Treatment Decisions: Current and Emerging Tests

bioTheranostics

Genomic Health

Tests in Development for Prediction of Breast Cancer Metastases

Analysis of the Expression of Multiple Genes for Other Cancer Applications: Current

and Emerging Tests

bioTheranostics

Genomic Health

Pathwork Diagnostics

Analysis of Lymph Nodes to Detect Metastasis of Breast Cancer

Other Molecular Tests for Breast Cancer

Abbott Molecular

ExonHit Therapeutics and bioMerieux

Screening for Colorectal Cancer: Stool-Based DNA Screening

Exact Sciences

OncoMethylome Sciences

Colorectal Cancer and K-RAS Mutations

Other Molecular Tests for Colorectal Cancer

DiagnoCure

Epigenomics

ExonHit Therapeutics and bioMérieux

OncoMethylome Sciences

Molecular Tests for Prostate Cancer

CombiMatrix

Epigenomics

ExonHit Therapeutics and bioMerieux

Gen-Probe

Leukemias and Lymphomas

Abbott Molecular

Asuragen

CombiMatrix

InVivoScribe Technologies

Roche Molecular Diagnostics

Selected Other Companies with Molecular Tests for Leukemia and Lymphoma

Outside the United States

UGT1A1 Genetic Variants

Third Wave Technologies

AutoGenomics

DNA Methylation Tests and Cancer

Epigenomics

OncoMethylome Sciences

Orion Genomics

Rubicon Genomics

Human Papillomavirus and Cervical Cancer Screening

Other Current and Emerging Molecular Tests for Oncology

Abbott Molecular

Asuragen

Myriad Genetics

Roche Molecular Diagnostics

3.2. Personalized Medicine; Pharmacogenomics and Companion Diagnostics: Moving Beyond Oncology

Cytochrome P450 and Drug Metabolism

Pharmacogenomic Test for Warfarin Response

Thiopurine Methyltransferase and Metabolism of Thiopurine Drugs

Pharmacogenetics and Response to Antiretroviral Therapy (Anti-HIV Therapy)

Other Molecular Diagnostics Personalized Medicine Tests

AutoGenomics

PGx Health (Part of Clinical Data)

3.3. Genetic Testing: For Inherited Disorders and Prenatal Diagnostics

Cystic Fibrosis

Prenatal Diagnosis

Abbott Molecular

CombiMatrix

Sequenom

Signature Genomic Laboratories

Ashkenazi Jewish Genetic Panel

Comparative Genomic Hybridization Microarrays

Other Current and Emerging Molecular Tests for Inherited Disorders

3.4. Genetic Testing: Predicting Risk of Disease

Risk of Venous Thromboembolism

Predicting Risk of Developing Cancer

Myriad Genetics

deCODE Genetics

Risk of Developing Alzheimer's Disease

Athena Diagnostics

Innogenetics

Risk of Cardiovascular Diseases

deCODE Genetics

Other Emerging Molecular Tests for Predicting Risk of Disease

CombiMatrix

deCODE Genetics

3.5. Tables

Chapter 4

BUSINESS CONSIDERATIONS IN MOLECULAR DIAGNOSTICS

4.1. Molecular Diagnostics Market Overview

4.2. Major Trends in the Molecular Diagnostics Market

Automation, Ease of Use

Moving Selected Molecular Diagnostic Tests Nearer to the Patient

Growth in Number of New Biomarkers

Increasing Efforts on Clinical Validation of Tests

Increasing Number of Tests Commercially Available

Launching New Tests Through CLIA-Certified Laboratories

Impact of FDA Regulations

Growing Number of FDA-Cleared and Approved Tests

Consolidation (Acquisitions)

Competition

Increasing Role of Personalized Medicine

4.3. Personalized Medicine and Molecular Diagnostics

Treatment of Infectious Diseases

Companion Diagnostics and Targeted Therapies

Other Personalized Medicine Tests

4.4. Major Challenges Facing Molecular Diagnostic Companies

Challenges Associated with Personalized Medicine Market Segment

Regulatory Issues and Considerations

Regulatory Issues and Considerations for Molecular Diagnostics Clinical Laboratories

Regulatory Issues and Considerations for Molecular Diagnostic Companies

Regulatory Issues and Consideration for Pharmaceutical Companies Developing Pharmacogenomic Therapies

Reimbursement of Molecular Diagnostics

Patient and Physician Education

Identification of New Biomarkers; Validation of Biomarkers and Diagnostic Tests

Chapter 5

EXPERT INTERVIEWS

Jeremy Bridge-Cook, PhD, Vice President, Luminex Molecular Diagnostics, Luminex Corporation, Austin, TX

David Craford, Vice President, Commercial Operations, Pathwork Diagnostics, Sunnyvale, CA

Amit Kumar, PhD, CEO and President, CombiMatrix Corporation, Mukilteo, WA

Fareed Kureshy, Founder, Chairman, President, and CEO, AutoGenomics, Carlsbad, CA

Jeffrey E. Miller, PhD, CSO, CEO, and Chairman, InVivoScribe Board of Directors,

InVivoScribe Technologies, San Diego, CA

Mansoor Mohammed, PhD, President and CEO, CombiMatrix Molecular Diagnostics (CMDX) (subsidiary of CombiMatrix Corporation), Irvine, CA

Oliver Schacht, PhD, CFO and CEO, Epigenomics Inc., Epigenomics AG, Berlin, Germany

John C. Schafer, President and CEO, DiagnoCure, Quebec, Canada

James White, CEO, Osmetech plc, Pasadena, CA

Matt Winkler, PhD, CEO and CSO, Asuragen, Austin, TX

References

Company Index with Web Addresses

To order this report:

Molecular Diagnostics: A Dynamic and Rapidly Broadening Market

http://www.reportlinker.com/p0156566/Molecular-Diagnostics-A-Dynamic-and-Rapidly-Broadening-Market.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    Contact
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
2. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Reportlinker Adds Nanomedicine Report
5. Reportlinker Adds Small Molecule Kinase Inhibitors Report
6. Reportlinker Adds Nanoporous Materials Report
7. Reportlinker Adds Membrane Bioreactors Report
8. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
9. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Reportlinker Adds Stem Cell Therapeutics Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)...  Allergan plc (NYSE: AGN ) a leading ... , Allergan,s CEO and President, will be featured as ... the RBC Capital Markets Healthcare Conference on Tuesday, February ... York Palace Hotel in New York, NY ... can be accessed on Allergan,s Investor Relations web site ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare Medical, LLC reports ... program, Sonalinkā„¢ remote monitoring. The inaugural launch of this new technology occurred over ... Dr. Samuel Peretsman to a HIFU technical expert at SonaCare Medical headquarters. ...
(Date:2/10/2016)... ... February 09, 2016 , ... Creation Technologies, ... of the Highest Overall Customer Rating Award from Circuits Assembly , today announced ... across the USA, Canada, Mexico and China. , The EMS provider, known in ...
(Date:2/9/2016)... ... 2016 , ... Clinovo , the cloud-based eClinical software ... Capture (EDC) system ClinCaptureand its new Contract Research Organization (CRO) Partner Program ... San Mateo, California on February 10th and 11th. Watch 2-min video . ...
Breaking Biology Technology:
(Date:1/25/2016)... , Jan. 25, 2016  Glencoe Software, the world-leading ... and publication industries, will provide the data management solution ... (NPSC). ... Phenotypic analysis measures the ... organisms, allowing comparisons between states such as health and ...
(Date:1/21/2016)... , January 21, 2016 ... to a new market research report "Emotion Detection and ... Others), Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020", published by MarketsandMarkets, ... expected to reach USD 22.65 Billion by 2020, ...
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
Breaking Biology News(10 mins):